Valerio Ceriani1, Francesco Cetta1, Tiziana Lodi1, Ferdinando Pinna1, Antonio E Pontiroli2,3. 1. Istituto di Ricovero e Cura a Carattere Scientifico Multimedica, Milan, Italy. 2. Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy. antonio.pontiroli@unimi.it. 3. Ospedale San Paolo, Via Antonio di Rudinì 8, 20142, Milan, Italy. antonio.pontiroli@unimi.it.
Abstract
BACKGROUND: Biliopancreatic diversion (BPD) is a bariatric technique burdened, in some instances, by clinical evidence of malabsorption and malnutrition, and by intractable diarrhea. OBJECTIVE: The objective of this study was to assess metabolic and nutritional effects on patients undergoing BPD and BPD plus revisional surgery because of side effects. METHODS: Thirty-five consecutive BPD patients underwent revisional surgery (elongation of the common limb from 50 to 200 cm and reduction of the gastric pouch from 500 to 40 ml) after a median 48-month period [48.3 ± 9.17 months (mean ± SD)] and were observed for a total period of 116.2 ± 6.21 months; 88 patients only undergoing BPD (controls) were observed for 120 months. RESULTS: Revisional surgery significantly improved side effects of BPD, with resolution of clinical symptoms in most instances. After revisional surgery, patients had a further decrease of body weight. The effect on disappearance of diabetes mellitus (DM) was remarkable, with no difference between revisional surgery and BPD. Triglycerides and transaminases decreased in a similar way, while cholesterol levels differed significantly. Estimated glomerular filtration rate improved. Nutritional parameters were similarly affected. CONCLUSION: This study suggests that it is possible to maintain the clinical and metabolic effects of BPD after a revisional procedure that leads to lesser malabsorption and to a greater restriction of the stomach. In particular, the positive effects on DM still persist after revisional surgery. This approach should be kept in mind in the presence of significant side effects due, inter alia, to excessive malabsorption.
BACKGROUND: Biliopancreatic diversion (BPD) is a bariatric technique burdened, in some instances, by clinical evidence of malabsorption and malnutrition, and by intractable diarrhea. OBJECTIVE: The objective of this study was to assess metabolic and nutritional effects on patients undergoing BPD and BPD plus revisional surgery because of side effects. METHODS: Thirty-five consecutive BPD patients underwent revisional surgery (elongation of the common limb from 50 to 200 cm and reduction of the gastric pouch from 500 to 40 ml) after a median 48-month period [48.3 ± 9.17 months (mean ± SD)] and were observed for a total period of 116.2 ± 6.21 months; 88 patients only undergoing BPD (controls) were observed for 120 months. RESULTS: Revisional surgery significantly improved side effects of BPD, with resolution of clinical symptoms in most instances. After revisional surgery, patients had a further decrease of body weight. The effect on disappearance of diabetes mellitus (DM) was remarkable, with no difference between revisional surgery and BPD. Triglycerides and transaminases decreased in a similar way, while cholesterol levels differed significantly. Estimated glomerular filtration rate improved. Nutritional parameters were similarly affected. CONCLUSION: This study suggests that it is possible to maintain the clinical and metabolic effects of BPD after a revisional procedure that leads to lesser malabsorption and to a greater restriction of the stomach. In particular, the positive effects on DM still persist after revisional surgery. This approach should be kept in mind in the presence of significant side effects due, inter alia, to excessive malabsorption.
Authors: Varun Agrawal; Kevin R Krause; David L Chengelis; Kerstyn C Zalesin; Leslie L Rocher; Peter A McCullough Journal: Surg Obes Relat Dis Date: 2008-08-05 Impact factor: 4.734
Authors: Kosisochi M Obinwanne; Kyla A Fredrickson; Michelle A Mathiason; Kara J Kallies; John P Farnen; Shanu N Kothari Journal: J Am Coll Surg Date: 2013-11-01 Impact factor: 6.113
Authors: N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli Journal: World J Surg Date: 1998-09 Impact factor: 3.352
Authors: John B Buse; Sonia Caprio; William T Cefalu; Antonio Ceriello; Stefano Del Prato; Silvio E Inzucchi; Sue McLaughlin; Gordon L Phillips; R Paul Robertson; Francesco Rubino; Richard Kahn; M Sue Kirkman Journal: Diabetes Care Date: 2009-11 Impact factor: 19.112
Authors: Hakeam A Hakeam; Patrick J O'Regan; Abdulrahman M Salem; Fahad Y Bamehriz; Abdelmoneim M Eldali Journal: Obes Surg Date: 2009-07-15 Impact factor: 4.129
Authors: Laura Folini; Annamaria Veronelli; Alberto Benetti; Carlo Pozzato; Marco Cappelletti; Enzo Masci; Giancarlo Micheletto; Antonio E Pontiroli Journal: Acta Diabetol Date: 2013-10-02 Impact factor: 4.280
Authors: Alberto Benetti; Marina Del Puppo; Andrea Crosignani; Annamaria Veronelli; Enzo Masci; Francesca Frigè; Giancarlo Micheletto; Valerio Panizzo; Antonio E Pontiroli Journal: Diabetes Care Date: 2012-12-28 Impact factor: 19.112
Authors: Valerio Ceriani; Giuliano Sarro; Giancarlo Micheletto; Alessandro Giovanelli; Ahmed S Zakaria; Marco Fanchini; Chiara Osio; Italo Nosari; Alberto Morabito; Antonio E Pontiroli Journal: Int J Obes (Lond) Date: 2018-11-23 Impact factor: 5.095
Authors: Valerio Ceriani; Ferdinando Pinna; Antonio Galantino; Ahmed S Zakaria; Roberto Manfrini; Antonio E Pontiroli; Franco Folli Journal: Acta Diabetol Date: 2021-08-28 Impact factor: 4.280